Cannabis Sativa, Inc. 

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Cannabis Sativa, Inc. engages in the telemedicine business while seeking opportunities in brand development and marketing of products and services to the cannabidiol and marijuana industries. Its Telemedicine, PrestoCorp offers an online telemedicine platform providing customers with access to knowledgeable physicians to obtain a medical marijuana recommendation. The company was founded on November 5, 2005 and is headquartered in Mesquite, NV.

MESQUITE, NV / ACCESSWIRE / January 17, 2024 / Cannabis Sativa, Inc. (OTCQB:CBDS) announces that PrestoDoctor - the #1 patient-rated medical cannabis telemedicine service - now offers its online medical cannabis card service to patients in the state of West Virginia. "Our trusted telemedicine portal is ready to provide West Virginia medical cannabis patients with easy and confidential access and education via an online appointment with a knowledgeable licensed medical doctor" said PrestoDoctor COO Rob Tankson.

PrestoDoctor Expands Its Cannabis Telemedicine Service to West Virginia

MESQUITE, NV / ACCESSWIRE / January 10, 2024 / Cannabis Sativa, Inc. (OTCQB:CBDS) announces that PrestoDoctor - the #1 patient-rated medical cannabis telemedicine service - now offers its online medical cannabis card service to patients in the state of Arkansas. "Our trusted telemedicine portal is ready to provide Arkansas medical cannabis patients with easy and confidential access and education via an online appointment with a knowledgeable licensed medical doctor," said PrestoDoctor COO Rob Tankson.

PrestoDoctor Expands its Cannabis Telemedicine Service to Arkansas

LAS VEGAS, NV / ACCESSWIRE / December 4, 2023 / Cannabis Sativa, Inc. (OTCQB:CBDS) announces that PrestoDoctor - the #1 patient-rated medical cannabis telemedicine service - now offers its online medical cannabis card service to patients in the state of Ohio. "Our trusted telemedicine portal is ready to provide Ohio medical cannabis patients with easy and confidential access and education via an online appointment with a knowledgeable licensed medical doctor" said PrestoDoctor COO Rob Tankson.

PrestoDoctor Expands its Cannabis Telemedicine to Ohio

LAS VEGAS, NV / ACCESSWIRE / April 20, 2023 / Cannabis Sativa, Inc. (OTCQB:CBDS) announces that PrestoDoctor will give on-site evaluations at the 9th annual Pennsylvania Cannabis Festival, Pocono 420, at the Pocono Raceway in Long Pond, Pennsylvania on April 22-23. "Attendees seeking a medical cannabis recommendation will be able to complete their medical evaluation quickly and easily at the festival," stated COO Rob Tankson.

PrestoDoctor to Offer On-site Evaluations at Pennsylvania Cannabis Festival April 22-23 at Pocono Raceway

MESQUITE, NV / ACCESSWIRE / December 20, 2022 / Cannabis Sativa, Inc. (OTCQB:CBDS) announces that PrestoDoctor - the #1 patient-rated medical cannabis telemedicine service - now offers its online medical cannabis card service to patients in the state of Louisiana. "Our trusted telemedicine portal is ready to provide Louisiana medical cannabis patients with easy and confidential access and education via an online appointment with a knowledgeable licensed medical doctor" said PrestoDoctor COO Rob Tankson.

PrestoDoctor Expands its Cannabis Telemedicine Service to Louisiana

LAS VEGAS, NV / ACCESSWIRE / August 11, 2022 / Cannabis Sativa, Inc. ("CBDS") (OTCQB:CBDS) announced that it has entered into a definitive Agreement of Merger and Plan of Reorganization (the "Merger Agreement") to mergewithMJ Harvest, Inc. ("MJHI"). The Merger Agreement was executed on August 8, 2022 and management expects the merger and reorganization to be completed in the fourth quarter of calendar year 2022 subject to certain conditions precedent including shareholder approval by both CBDS and MJHI shareholders.

Cannabis Sativa, Inc. Announces the Signing of the Definitive Plan of Merger and Reorganization

MESQUITE, NV / ACCESSWIRE / June 22, 2022 / Cannabis Sativa, Inc. (OTCQB:CBDS) announces that PrestoDoctor - the #1 patient-rated medical cannabis telemedicine service - now offers its online medical cannabis card service to patients in the state of Texas. PrestoDoctor COO Rob Tankson said, "Our trusted telemedicine portal is ready to provide Texas medical cannabis patients with easy and confidential access and education via an online appointment with a knowledgeable licensed medical doctor.

PrestoDoctor Expands Cannabis Telemedicine Service to Texas

MESQUITE, NV / ACCESSWIRE / May 11, 2022 / Cannabis Sativa Inc. ("CBDS")(OTCQB:CBDS) announced that it has signed a Letter of Intent ("LOI") to merge with MJ Harvest, Inc. ("MJHI"). The merger, if consummated, represents a shift in the operations of CBDS from its current telehealth business toward a focus on the vertically integrated cannabis business being developed by MJHI.

Cannabis Sativa Announces a Letter of Intent to Merge with MJ Harvest, Inc.

MESQUITE, NV / ACCESSWIRE / April 19, 2022 / Cannabis Sativa, Inc.(OTCQB:CBDS) is excited to announce that PrestoDoctor will give on-site evaluations at the 8th Annual Pennsylvania Cannabis Festival live event "Freedom Through Growth" on Saturday, April 23 to Sunday, April 24 at Renninger's Farmers Market, 740 Noble St in Kutztown, Pennsylvania. Admission is free and features over 250 vendors, live music, speakers, and discussion panels.

PrestoDoctor to Offer On-site Evaluations at Pennsylvania Cannabis Festival April 23-24

MESQUITE, NV / ACCESSWIRE / January 17, 2022 / Cannabis Sativa, Inc. (OTCQB:CBDS) announces that the cannabis compound CBGA found in its patented strain patented strain Equadorian Sativa, or CTA (US PP 27,475 - http://bit.ly/2te8hFk) has been found effective in blocking covid from entering human cells in a laboratory study published in the Journal of Natural Products (Cannabinoids Block Cellular Entry of SARS-CoV‑2 and the Emerging Variants - https://bit.ly/33FfgwE), but must be taken orally to potentially prevent and treat infection by SARS-CoV-2 according to the study. Cannabigerolic acid, or CBGA was identified during a chemical screening effort as having the potential to fight coronavirus by binding to spike proteins found on the virus, blocking its ability to infect people.

CBGA Found in Patented Strain Effective in Blocking Covid

News for Cannabis Sativa, Inc. Stock (CBDS)